New frontiers in translational control of the cancer genome

Truitt, Morgan L., Ruggero, Davide·2016·Nature Reviews Cancer

Cited by (388)

Items 201–300 of 388

  1. Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome
    Duygu Kuzuoğlu‐Öztürk, Zhiqiang Hu, Martina Rama, Emily N. Devericks, Jacob Weiss, Gary Gene Chiang, Stephen T. Worland, Steven E. Brenner, Hani Goodarzi, Luke A. Gilbert et al. · 2021 · Cell Reports
  2. PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma
    Bhargab Kalita, Gerard Martínez-Cebrián, Justina D. McEvoy, Melody Lyn Allensworth, Michelle Knight, Alessandro Magli, Rita C. R. Perlingeiro, Michael A. Dyer, Elizabeth A. Stewart, Brian David Dynlacht · 2024 · Cell
  3. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment
    Francesco Caiazza, Katarzyna Oficjalska, Miriam Tosetto, James Joseph Phelan, Sinead A. Noonan, Petra Martin, Kate E. Killick, Laura Breen, Fiona O’Neill, Bláthnaid Nolan et al. · 2019 · American Journal Of Pathology
  4. Non-Coding RNAs and Splicing Activity in Testicular Germ Cell Tumors
    Marco Barchi, Pamela Bielli, Susanna Dolci, Pellegrino Rossi, Paola Grimaldi · 2021 · Life
  5. Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development
    Annarita Sibilio, Clara Suñer, Marcos Fernández‐Alfara, Judit Martín, Antonio Berenguer, Alexandre Calon, Verónica Chanes, Alba Millanes‐Romero, Gonzalo Fernández‐Miranda, Eduard Batlle et al. · 2022 · iScience
  6. Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study
    A. Scagliola, A. Miluzio, G. Mori, Sara Ricciardi, S. Oliveto, Nicola Manfrini, S. Biffo · 2022 · International Journal of Molecular Sciences
  7. Dynamic Regulation of tRNA Modifications in Cancer
    Pierre Close, Debojit Bose, Alain Chariot, Sebastian A. Leidel · 2017 · Elsevier eBooks
  8. Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation
    Nhu Nguyen, Kristbjorn O. Gudmundsson, Anthony R. Soltis, Kevin Oakley, Kartik R. Roy, Yufen Han, Carmelo Gurnari, Jaroslaw Pawel Maciejewski, Gary D. Crouch, Patricia Ernst et al. · 2021 · iScience
  9. BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562 cells
    Yu Kato, Kazuhiro Kunimasa, Yoshikazu Sugimoto, Akihiro Tomida · 2018 · Biochemical and Biophysical Research Communications
  10. Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer
    Christos Vaklavas, Scott W. Blume, William E. Grizzle · 2020 · Translational Oncology
  11. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma
    Dongjun Dai, Rongkai Shi, Shuting Han, Hongchuan Jin, Xian Wang · 2020 · Medicine
  12. Comprehensive quantitative modeling of translation efficiency in a genome‐reduced bacterium
    Marc L Weber, Adrià Sogues, Eva Yus, Raul Burgos, Carolina Gallo, Sira Martínez, María Lluch‐Senar, Luis G. Serrano · 2023 · Molecular Systems Biology
  13. PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
    Hiroaki Matsubara, Takeshi Fukuda, Yuichiro Awazu, Shigenori Nanno, Masahiro Shimomura, Yuta Inoue, Makoto Yamauchi, Tomoyo Yasui, Toshiyuki Sumi · 2020 · Oncology Letters
  14. Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties
    Rossella Lucà, Maria Rita Assenza, Fabio Maiullari, Luisa Pieroni, Silvia Maiullari, Giulia Federici, Federica Marini, Roberto Rizzi, Andrea Urbani, Silvia Soddu et al. · 2021 · Cell Death and Disease
  15. Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathways
    Anna Herrmannová, Jan Jelı́nek, Klára Pospíšilová, Farkas Kerényi, Tomáš Vomastek, Kathleen Watt, Jan Brábek, Mahabub Pasha Mohammad, Susan Wagner, Ivan Topisirović et al. · 2024 · eLife
  16. Ribosome changes reprogram translation for chemosurvival in G0 leukemic cells
    Chandreyee Datta, Samuel Spencer Truesdell, Keith Q. Wu, Syed I. A. Bukhari, Harrison Ngue, Brienna Buchanan, Olivier Le Tonquèze, Sooncheol Lee, Swapna Kollu, Madeleine A. Granovetter et al. · 2022 · Science Advances
  17. Comparing intestinal versus diffuse gastric cancer using a PEFF-oriented proteomic pipeline
    Helisa H. Wippel, Marlon Dias Mariano Santos, Milan Avila Clasen, Louise Ulrich Kurt, Fábio César Sousa Nogueira, Carlos Eduardo de Souza Carvalho, Thaís Messias McCormick, Guilherme Pinto Bravo Neto, Lysangela Ronalte Alves, Maria da Glória Carvalho et al. · 2017 · Journal of Proteomics
  18. Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
    Adva Kochavi, Remco Nagel, Pierre-René Körner, Onno B. Bleijerveld, Chun‐Pu Lin, Zowi R. Huinen, Yuval Malka, Natalie Proost, Marieke van de Ven, Xiaodong Feng et al. · 2024 · Nucleic Acids Research
  19. CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis
    Maria Eugenia Delgado, Salvador Naranjo‐Suarez, Marta Ramírez-Pedraza, Beatriz Cárdenas, Carmen Gallardo-Martínez, Alexandra Balvey, Eulàlia Belloc, Judit Martín, Mark Boyle, Raúl Méndez et al. · 2024 · JHEP Reports
  20. Co-targeting translation and proteasome rapidly kills colon cancer cells with mutant RAS/RAF via ER stress
    Xiangyun Li, Mei Li, Hang Ruan, Wei Qiu, Xiang Ming Xu, Lin Zhang, Jian Yu · 2016 · Oncotarget
  21. Control of ribosomal protein synthesis by the Microprocessor complex
    Xuan Jiang, Amit Prabhakar, Stephanie M. van der Voorn, Prajakta Ghatpande, Barbara Celona, Srivats Venkataramanan, Lorenzo Calviello, Chuwen Lin, Wanpeng Wang, Brian L. Black et al. · 2021 · Science Signaling
  22. Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia
    Daniel Sjövall, Sudip Ghosh, Narcís Fernández‐Fuentes, Talía Velasco-Hernández, Anna Hogmalm, Pablo R. Menéndez, Jenny Hansson, Carolina Guibentif, Pekka Jaako · 2024 · Cell Reports
  23. Biomolecular condensates in immune cell fate
    Srikanth Kodali, Caroline M. Sands, Lei Guo, Yun Huang, Bruno Di Stefano · 2025 · Nature reviews. Immunology
  24. CIP2A regulates MYC translation (via its 5′UTR) in colorectal cancer
    Sarah Denk, Stefanie Schmidt, Y. Schurr, G. Schwarz, F. Schote, Markus E. Diefenbacher, C. Armendariz, Francesca R. Dejure, Martin Eilers, Armin Wiegering · 2020 · International Journal of Colorectal Disease
  25. A small natural molecule CADPE kills residual colorectal cancer cells by inhibiting key transcription factors and translation initiation factors
    Guowan Zheng, Mingmin Tang, Chenyan Shu, Wenxiu Xin, Yanhua Zhang, Bin-Bin Chi, Muran Shi, Xing Guo, Zhizhen Zhang, Xiao‐Yuan Lian · 2020 · Cell Death and Disease
  26. The functions and modifications of tRNA-derived small RNAs in cancer biology
    Abdulaziz Ahmed A. Saad, Kun Zhang, Qianqian Deng, Jiawang Zhou, Lichen Ge, Hongsheng Wang · 2025 · Cancer and Metastasis Reviews
  27. Regulation of mRNA translation by estrogen receptor in breast cancer
    Shahrzad Soleymani Fard, Marina K. Holz · 2023 · Steroids
  28. Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer
    Jing He, Ziwei Chen, Qingfeng Xue, Wenyu Shi · 2022 · Oxidative Medicine and Cellular Longevity
  29. Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion
    Laura Simone Bisogno, Matthew B. Friedersdorf, Jack D. Keene · 2018 · iScience
  30. STAT3‐mediated MLST8 gene expression regulates cap‐dependent translation in cancer cells
    Hyunji Lee, Hyunjung Chin, Hyeyoung Kim, Ho-Sung Jung, Daekee Lee · 2020 · Molecular Oncology
  31. A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy
    Zhiyi Zhao, Hongling Jia, Zhou Sun, Yumeng Li, Lingyun Liu · 2024 · Frontiers in Immunology
  32. Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma
    Morgane Le Bras, Noah Leviton Gorelick, Sylvain Pautet, Betty Tyler, Stéphane Manenti, Nicolas Skuli, Stefania Millevoi, Anne Cammas · 2022 · Cancers
  33. Alteration of 28S rRNA 2′-O-methylation by etoposide correlates with decreased SMN phosphorylation and reduced Drosha levels
    Marilyn F. Burke, Douglas M. McLaurin, Madelyn K. Logan, Michael D. Hebert · 2019 · Biology Open
  34. Organ-specific translation elongation rates measured by in vivo ribosome profiling
    Maxim V. Gerashchenko, Zalán Péterfi, Vadim N. Gladyshev · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  35. The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival
    Marcel Seibert, Sebastian E. Koschade, Verena Stolp, Björn Häupl, Frank Wempe, Hubert L. Serve, Nina Kurrle, Frank Schnütgen, Ivana von Metzler · 2023 · Cancers
  36. Furo[3,2-b]pyridine: Chemical synthesis, transformations and biological applications
    Sumayya Akram, Sana Aslam, Nasır Rasool, Matloob Ahmad, Sami A. Al‐Hussain, Magdi E. A. Zaki · 2024 · Journal of Saudi Chemical Society
  37. Ribosomes: from conserved origin to functional/medical mobility and heterogeneity
    André Rivalta, Disha‐Gajanan Hiregange, Tanaya Bose, K. Shanmugha Rajan, Ada Yonath, Ella Zimmerman, Miriam Waghalter, Gil Fridkin, Irene Martinez-Roman, Liat Rosenfield et al. · 2025 · Philosophical Transactions of the Royal Society B Biological Sciences
  38. Hidden Targets in Cancer Immunotherapy: The Potential of “Dark Matter” Neoantigens
    Francois Xavier Rwandamuriye, Alec Redwood, Jenette Creaney, Bruce W. S. Robinson · 2026 · Vaccines
  39. Intricate ribosome composition and translational reprogramming in epithelial–mesenchymal transition
    Chloé Morin, Agnès Baudin‐Baillieu, Flora Nguyen Van Long, Caroline Isaac, Laure Bidou, Hugo Arbès, Pauline François, Roxane M. Pommier, Annie Adrait, Akari Saku et al. · 2024 · Proceedings of the National Academy of Sciences
  40. Generation of ribosome imprinted polymers for sensitive detection of translational responses
    Helen A. King, Hazim F. EL-Sharif, Ana M. Matia‐González, Valentina Iadevaia, Adeola Fowotade, Subrayal M. Reddy, André P. Gerber · 2017 · Scientific Reports
  41. Variety of Non-Coding RNAs in Eukaryotic Genomes
    Nafisa Nailovna Nazipova · 2021 · Mathematical Biology and Bioinformatics
  42. Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
    Dechao Feng, Zhouting Tuo, Jie Wang, Luxia Ye, Dengxiong Li, Ruicheng Wu, Wuran Wei, Yubo Yang, Chi Zhang · 2023 · Heliyon
  43. PTBP1 and Cancer: From RNA Regulation to Therapeutic Potential
    Chengdong Ji, Jing Zhu, Xiaochen Hou, Chen Zhou, Jiumei Zhao, Xiang Zheng, Yu Tang · 2025 · Journal of Cellular and Molecular Medicine
  44. MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis
    Wentao Gui, Petr Páral, Bhavuk Dhamija, Eman Hagag, Martin Dusa, Jana Humajová, Pavla Francová, Jan Kučka, Jan Pankrác, Caroline Schütz et al. · 2025 · Nature Communications
  45. Context-dependent translation inhibition as a cancer therapeutic modality
    Paige D. Diamond, Paul Victor Sauer, Mikael Holm, Canessa J. Swanson-Swett, Lucas Ferguson, Natalie M. Bratset, Grant W. Wienker, Justin Seiwert Sim, Hailey Adams, Lillian R. Kenner et al. · 2026 · Nature Communications
  46. Translation initiation and its relationship with metabolic mechanisms in cancer development, progression and chemoresistance
    Andrea Muñoz-Ayala, Brenda Chimal‐Vega, Víctor García‐González · 2022 · Advances in protein chemistry and structural biology
  47. eIF3d specialized translation requires a RACK1-driven eIF3d binding to 43S PIC in proliferating SH-SY5Y neuroblastoma cells
    Federica Silvestri, Raffaele Montuoro, Elisabetta Catalani, Francesca Tilesi, Daniela Willems, Nicla Romano, Sara Ricciardi, Davide Cervia, Marcello Ceci · 2024 · Cellular Signalling
  48. Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
    Yiyuan Feng, Sha Zhu, Tengwen Liu, Guoguo Zhi, Bingjie Shao, Jibin Liu, Baixue Li, Cen Jiang, Quansheng Feng, Peijie Wu et al. · 2023 · Pharmaceuticals
  49. Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer
    Elisa Pasqua, Birgit Wilding, Matthew D. Cheeseman, Keith Jones · 2017 · Elsevier eBooks
  50. Wobble uridine tRNA modification: a new vulnerability of refractory melanoma
    Francesca A. Rapino, Pierre Close · 2018 · Molecular & Cellular Oncology
  51. Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells
    Benno Verbelen, Tiziana Girardi, Sergey O. Sulima, Stijn Vereecke, Paulien Verstraete, Jelle Verbeeck, Jonathan Royaert, Sonia Cinque, Lorenzo Montanaro, Marianna Penzo et al. · 2022 · Engineering in Life Sciences
  52. SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer
    Ariane Mora, Christina Schmidt, Brad Balderson, Christian Frezza, Mikael Bodén A · 2024 · Genome Medicine
  53. Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function
    Swee Y. Sharp, Marianna Martella, Sabrina D’Agostino, Christopher I. Milton, George Ward, Andrew Woodhead, Caroline J. Richardson, Maria G. Carr, Elisabetta Chiarparin, Benjamin D. Cons et al. · 2024 · Nature Communications
  54. An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation
    Mónica Román-Trufero, Istvan T. Kleijn, Kevin Blighe, Jinglin Zhou, Paula Saavedra-García, Abigail Gaffar, Marilena Christoforou, Axel Bellotti, Joel M. Abrahams, Abdelmadjid Atrih et al. · 2025 · Life Science Alliance
  55. Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation
    Clare G. Fedele, Gamze Kuser Abali, Ralph Rossi, Peinan Zhao, Jason Li, Pacman Szeto, Youfang Zhang, Nicholas C. Wong, Miles Cameron Andrews, Mark J. Shackleton · 2025 · Pigment Cell & Melanoma Research
  56. TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
    Jamilah Abusarah, Yun Cui, Nehmé El-Hachem, Abed El-Hakim El-Kadiry, Ian Hammond-Martel, Hugo Würtele, Annie Beaudry, Noël J.‐M. Raynal, Francis Robert, Jerry Pelletier et al. · 2020 · Molecular Cancer Therapeutics
  57. Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
    Wenqi Wu, Jinhuan Wang, Yanan Jiang, Xin Hu, Ye Tian, Long Chen, Huimeng Sun, Yuhang Li, Su Liu, Yangyang Lv et al. · 2023 · Journal of Cancer
  58. Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours
    Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa · 2024 · International Journal of Molecular Sciences
  59. Development of a novel peptide aptamer that interacts with the eIF4E capped-mRNA binding site using peptide epitope linker evolution (PELE)
    Yuri Frosi, Simon Ng, Yen‐Chu Lin, Shimin Jiang, Siti Radhiah Ramlan, Dilraj Lama, Chandra Shekhar Verma, Ignacio Asial, Christopher John Brown · 2022 · RSC Chemical Biology
  60. Translation rewiring at the heart of phenotype switching in melanoma
    Eleonora Leucci, Pierre Close, Jean‐Christophe Marine · 2017 · Pigment Cell & Melanoma Research
  61. Ribosome homeostasis
    Michael Buszczak · 2022 · Seminars in Cell and Developmental Biology
  62. Characterization of RNA Processing Genes in Colon Cancer for Predicting Clinical Outcomes
    Jianwen Hu, Yingze Ning, Yongchen Ma, Lie Sun, Guowei Chen · 2024 · Biomarker Insights
  63. mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery
    Julia Hermann, Toman Borteçen, Robert Kalis, Alexander Kowar, Catarina Pechincha, Vivien Vogt, Martin Schneider, Dominic Helm, Jeroen Krijgsveld, Fabricio Loayza‐Puch et al. · 2025 · Nature Communications
  64. Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy
    Riham M. Bokhtia, Kunj Bihari Gupta, Annabella Natalini, Theerth Vikas Srinivasan, Nihal Amineni, Sophia Ying, Rajeev Shakuja, Guido F. Verbeck, Bal L. Lokeshwar, Siva S. Panda · 2025 · Molecules
  65. Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
    Chitra Subramanian, Katie K. Spielbauer, Robin E. Pearce, Kevin J. Kovatch, Mark E. Prince, Barbara N. Timmermann, Mark Steven Cohen · 2022 · Nutrients
  66. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants
    Myoung Eun Choi, Eun‐Ji Choi, Jeong Hyeon Lee, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Woo Jin Lee · 2024 · British Journal of Dermatology
  67. The Paradox of Ribosomal Insufficiency Coupled with Increased Cancer: Shifting the Perspective from the Cancer Cell to the Microenvironment
    Giacomo D’Andrea, Giorgia Deroma, Annarita Miluzio, Stefano Biffo · 2024 · Cancers
  68. Regulation of Protein Synthesis by eIF4E in the Brain
    Kleanthi Chalkiadaki, Stella Kouloulia, Clive R. Bramham, Christos G. Gkogkas · 2020 · Oxford University Press eBooks
  69. Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer
    Joanna R. Kovalski, Yichen Xu, Davide Ruggero · 2021 · Methods in molecular biology
  70. Integrin β1 mediates 5-fluorouracil chemoresistance under translational control of eIF4E in colorectal cancer.
    Zhengchuan Niu, Pingping Xu, Dexiang Zhu, Wentao Tang, Meiling Ji, Qi Lin, Tianyu Liu, Li Ren, Ye Wei, Jianmin Xu · 2018 · Europe PMC (PubMed Central)
  71. METTL1‐Mediated N 7 ‐Methylguanosine tRNA Modification Alleviates Cardiac Ischemia/Reperfusion Injury by Modulating Mitochondrial Energy Metabolism
    Yue Zhang, Mingyang Leng, Ruonan Wang, Xinyuan Tang, Zhenlu Cai, Liang Wang, Xiaoqi Shao, Hongtao Diao, Qinqiang Long, Li Xu et al. · 2026 · MedComm
  72. 5.8S rRNA forms and ribosome heterogeneity in breast cancer
    Giulia Venturi, Federico Zacchini, Francesca Ruzzi, Angelo Gianluca Corradini, Margherita Serra, Marianna Penzo, Davide Treré, Pier‐Luigi Lollini, Lorenzo Montanaro · 2025 · Biochimie
  73. The Role of tRNA-Centered Translational Regulatory Mechanisms in Cancer
    Yuanjian Shi, Yipeng Feng, Qinglin Wang, Gaochao Dong, Wenjie Xia, Feng Jiang · 2023 · Cancers
  74. Ribosomal rodeo: wrangling translational machinery in gynecologic tumors
    Kamil Filipek, Marianna Penzo · 2024 · Cancer Metastasis Review
  75. Genetic context and proliferation determine contrasting patterns of copy number amplification and loss for 5S and 45S ribosomal DNA arrays in cancer
    Meng Wang, Bernardo Lemos · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  76. RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs
    Pierre Murat, Giovanni Marsico, Barbara Herdy, Avazeh Tashakkori Ghanbarian, Guillem Portella, Shankar Balasubramanian · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Human Puf-A, a Novel Component of 90S Pre-ribosome, Links Ribosome Biogenesis to Cancer Progression
    Huan-Chieh Cho, Yenlin Huang, Jung‐Tung Hung, Li‐Chun Lai, Sheng‐Hung Wang, Yun‐Hen Liu, I-Ming Cho, Ming-Wei Kuo, Pei-Yi Cheng, Ming‐Yi Ho et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  78. A stress-induced Tyrosine tRNA depletion response mediates codon-based translational repression and growth suppression
    Doowon Huh, Maria C. Passarelli, Jenny Gao, Shahnoza N Dusmatova, Clara Goin, Lisa Fish, Alexandra M. Pinzaru, Henrik Molina, Elizabeth A. McMillan, Hosseinali Asgharian et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
    Na Zhao, Elena B. Kabotyanski, Alexander B. Saltzman, Anna Malovannaya, Xueying Yuan, Lucas Charles Reineke, Nadia Lieu, Yang Gao, Diego A. Pedroza, Sebastian J. Calderon et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  80. RNA G-quadruplex dynamic steers the crosstalk between protein synthesis and energy metabolism
    Leïla Dumas, Sauyeun Shin, Quentin Rigaud, Marie Cargnello, Beatriz Hernández Suárez, Pauline Herviou, Nathalie Saint‐Laurent, Marjorie Leduc, Morgane Le Gall, David Monchaud et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Targeting of Post-Transcriptional Regulation as Treatment Strategy in Acute Leukemia
    Paulina Podszywalow‐Bartnicka, Magdalena Wołczyk, Katarzyna Piwocka · 2020 · IntechOpen eBooks
  82. The implication of non-AUG-initiated N-terminally extended proteoforms in cancer
    Rita Pancsa, Dmitry E. Andreev, Kellie A. Dean · 2025 · RNA Biology
  83. Identification of a Novel Intracellular Function of the Secreted Ribonuclease RNASE1 in Inhibiting Gene Expression
    Ragini Singh, Ahlina Archibald, Xiao Ling Li, Ravi Shekhar Kumar, Shaoli Das, Erica C. Pehrsson, Patrick Xuechun Zhao, Xinyu Wen, Raj Chari, Ioannis Grammatikakis et al. · 2025 · Molecular and Cellular Biology
  84. Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs
    Jessica Finlay-Schultz, Kiran Vinod-Paul, Benjamin Erickson, Lynsey M. Fettig, Benjamin S. Hastings, Deborah L. Johnson, David L. Bentley, Peter Kabos, Carol A. Sartorius · 2025 · Nucleic Acids Research
  85. Evolutionary Transcriptomics of Cancer Development
    R. A. Ivanov, Dmitry A. Afonnikov, Yu. G. Matushkin, Sergey Alexandrovich Lashin · 2025 · International Journal of Molecular Sciences
  86. Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET
    Nisha K. Ramakrishnan, Helen Betts, Selena Milicevic Sephton, Xiaoyun Zhou, David J. Williamson, Stephen J. Sawiak, Franklin I. Aigbirhio · 2022 · Nuclear Medicine and Biology
  87. Alteration of ribosome function upon 5-fluorouracil treatment favours cancer cell drug-tolerance
    Gabriel Thérizols, Zeina Bash-Imam, Baptiste Panthu, Christelle Machon, Anne Vincent, Sophie Nait-Slimane, Maxime Garcia, Mounira Chalabi‐Dchar, Florian Laforêts, Virginie Marcel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  88. SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer
    Ariane Mora, Christina Schmidt, Brad Balderson, Christian Frezza, Mikael Bodén A · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. 4EBP1/2 support tumorigenicity and cell survival during energetic stress by translationally regulating fatty acid synthesis
    Tal Levy, Kai Voeltzke, Laura Hauffe, Khawla Alasad, Marteinn Snaebjörnsson, Ran Marciano, K. Scharov, M. Planque, K. Vriens, S. Christen et al. · 2022 · bioRxiv
  90. Regulation of RNA methylation by therapy treatment, promotes tumor survival
    Syed I. A. Bukhari, Samuel Spencer Truesdell, Chandreyee Datta, Pritha Choudhury, Keith Q. Wu, Jitendra Shrestha, Ruby Maharjan, Ethan Plotsker, Ramzi K. Elased, Sadia Laisa et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. The eIF4A2 negative regulator of mRNA translation promotes extracellular matrix deposition to accelerate hepatocellular carcinoma initiation
    Madeleine Moore, Luis Pardo, Louise E. Mitchell, Tobias Schmidt, Joseph A. Waldron, Stephanie May, Miryam Müller, Rachael C.L. Smith, Douglas Strathdee, Sheila Bryson et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathway
    Anna Herrmannová, Jan Jelı́nek, Klára Pospíšilová, Farkas Kerényi, Tomáš Vomastek, Kathleen Watt, Jan Brábek, Mahabub Pasha Mohammad, Susan Wagner, Ivan Topisirović et al. · 2024 · eLife
  93. Local translational program at the muscle-tendon junction endows domain identity in muscle syncytia
    Juliana de Carvalho Neves, Nour El Khazen, Coalesco Smith, Vedran Franke, Sakulrat Mankhong, Edgar Jauliac, Laura Yedigaryan, Elise Lefebvre, Altuna Akalins, Pascal Maire et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Depletion of rRNA Methyltranferase METTL5 Enhances Anti-Tumor Immune Response via Neoantigen Generated from Cryptic Translation
    Yangyi Zhang, Xiaoyan Shi, Yuci Wang, Ruiqi Wang, Folan Lin, Yanlan Cao, Wanqiu Li, Hao Chen · 2026 · eLife
  95. High cell throughput, programmable fixation reveals the RNA and protein co-regulation with spatially resolved NFκB pseudo-signaling
    Nicholas Y. Zhang, Mingshuang Wang, Dhruv Nambiar, Samyukta Iyer, Priyam Kadakia, Qianqi Luo, Sicheng Pang, Aaron Qu, Nivik Sanjay Bharadwaj, Peng Qiu et al. · 2024 · APL Bioengineering
  96. Optogenetic Control of the Integrated Stress Response Limits Glioblastoma Invasion
    Lisa K. Månsson, Ethan Dickson, Hao Li, Angela A. Pitenis, Maxwell Z. Wilson · 2026 · Cell Biochemistry and Function
  97. Discovery of a small-molecule inhibitor of eIF4E suppressing tumor proliferation via lipid metabolic reprogramming
    Yuxi Lin, Xiaoyi bai, Shuo Li, Hao Sun, Yiting Zhang, Chenxia Gao, Jiashu Chen, Yuanyuan Zhao, Yue Xu, Yanan Gao et al. · 2025 · Journal of Advanced Research
  98. TRANSAID: a hybrid deep learning framework for translation site prediction with integrated biological feature scoring
    Yan Li, Boran Wang, Zhen Liu, Wei Wei, Cai-Yi Fei, Shi Xu, Ti-Yun Han, Wei Geng, Zengding Wu · 2026 · Frontiers Bioinform.
  99. ENY2 transcription and export complex 2 subunit deficiency induces nucleolar stress to inhibit tumor progression through NPM1/MDM2/p53-dependent and -independent responses
    Shiqi Zuo, He S, Zhiqin Zhu, Yanjie Hou, Ziqing Wu, Yao Tang, Yujiao Zou · 2026 · Cellular Oncology
  100. Dysregulated selective translation in cancer: The pivotal functions of RNA-binding proteins and emerging therapeutic avenues
    Xiao Hu, Jiayan Xie, Yaping Li, Ke Li, Bin Wang · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer